Dafin F Muresanu Selected Research

Complement System Proteins (Complement)

1/2022	Role of RGC-32 in multiple sclerosis and neuroinflammation - few answers and many questions.
1/2020	RGC-32 Regulates Generation of Reactive Astrocytes in Experimental Autoimmune Encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dafin F Muresanu Research Topics

Disease

21	Edema (Dropsy) 06/2023 - 06/2010
15	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2012
13	Wounds and Injuries (Trauma) 06/2023 - 10/2013
12	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2012
11	Craniocerebral Trauma (Head Injury) 01/2023 - 01/2019
10	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 01/2015
9	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 10/2015
8	Stroke (Strokes) 02/2023 - 01/2016
8	Brain Edema (Cerebral Edema) 01/2021 - 01/2012
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2012
5	Brain Injuries (Brain Injury) 01/2023 - 01/2016
4	Sleep Deprivation 01/2023 - 01/2019
3	Multiple Sclerosis 03/2024 - 01/2023
3	Brain Concussion (Cerebral Concussion) 01/2023 - 01/2020
3	Dementia (Dementias) 01/2023 - 08/2009
3	Cognitive Dysfunction 05/2021 - 12/2007
3	Ischemic Stroke 05/2021 - 01/2019
2	Dysbiosis 03/2024 - 01/2024
2	Pain (Aches) 06/2023 - 03/2011
2	Heat Stroke (Heatstroke) 01/2021 - 01/2021
2	Ischemia 01/2016 - 01/2012
2	Brain Diseases (Brain Disorder) 01/2016 - 01/2012
2	Nervous System Diseases (Neurological Disorders) 10/2015 - 06/2011
2	Hypertension (High Blood Pressure) 10/2013 - 12/2007
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 12/2010 - 04/2008
2	Hyperthermia 08/2009 - 12/2007
1	Infections 03/2024
1	Inflammation (Inflammations) 03/2024
1	Hyperalgesia 06/2023
1	Neuralgia (Stump Neuralgia) 06/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023
1	Blast Injuries 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Neuroinflammatory Diseases 01/2022

Drug/Important Bio-Agent (IBA)

31	cerebrolysinIBA 06/2023 - 04/2008
16	Neuroprotective AgentsIBA 01/2023 - 12/2007
11	AntioxidantsIBA 01/2023 - 08/2009
9	Monoclonal AntibodiesIBA 01/2023 - 01/2023
9	AntibodiesIBA 01/2023 - 01/2017
8	Amyloid beta-PeptidesIBA 01/2023 - 01/2018
7	Evans Blue (Blue, Evans)FDA Link 06/2023 - 10/2013
7	Nerve Growth Factors (Neurotrophins)IBA 06/2023 - 06/2011
7	H290-51IBA 01/2023 - 08/2009
5	Histamine (Histamine Dihydrochloride)FDA Link 01/2023 - 01/2017
5	3-n-butylphthalide (butylphthalide)IBA 01/2023 - 01/2019
5	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2023 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2009
4	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 01/2023
3	AlbuminsIBA 06/2023 - 10/2013
3	MetalsIBA 06/2023 - 01/2021
3	Neprilysin (Neutral Endopeptidase)IBA 01/2023 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2023
3	EnzymesIBA 01/2023 - 01/2021
3	clobenpropitIBA 01/2023 - 01/2018
3	alpha-SynucleinIBA 01/2023 - 01/2023
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 03/2011
3	Growth Hormone (Somatotropin)IBA 10/2015 - 12/2007
2	Peptide FragmentsIBA 06/2023 - 01/2023
2	mesoglycanIBA 02/2023 - 01/2023
2	bilobalideIBA 01/2023 - 01/2021
2	Histamine AgentsIBA 01/2023 - 01/2017
2	oxiracetamIBA 01/2023 - 01/2021
2	ginkgolide BIBA 01/2023 - 01/2021
2	Ginkgo biloba extract (Rokan)IBA 01/2023 - 01/2021
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023 - 01/2019
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 03/2011
2	CytokinesIBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 10/2015
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021 - 03/2011
2	Insulin (Novolin)FDA Link 01/2021 - 10/2015
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 10/2015
2	Ciliary Neurotrophic Factor (CNTF)IBA 01/2021 - 03/2011
2	Therapeutic UsesIBA 01/2020 - 01/2018
2	Blood Proteins (Serum Proteins)IBA 01/2016 - 12/2014
2	UbiquitinIBA 01/2016 - 10/2015
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2015 - 03/2011
1	PrebioticsIBA 03/2024
1	IgYIBA 03/2024
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2024
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2023
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2023
1	Histamine Antagonists (Antihistamines)IBA 01/2023
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2023
1	Explosive Agents (Explosives)IBA 01/2023
1	SandIBA 01/2023
1	pitolisantIBA 01/2023
1	Histamine Receptors (Histamine Receptor)IBA 01/2023
1	SB 399885IBA 01/2023
1	Nicotine FDA Link 01/2023
1	serotonin 6 receptorIBA 01/2023
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022

Therapy/Procedure

11	Therapeutics 03/2024 - 12/2007
7	Drug Therapy (Chemotherapy) 01/2023 - 01/2015
2	Intravenous Administration 01/2019 - 01/2017
1	Fecal Microbiota Transplantation 03/2024
1	Precision Medicine 02/2023